EP2046298
Lyfjaskammtaform sem inniheldur lyfjafræðilega hæfa leysandi samsetningu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.7.2007EP published:
30.11.2016EP application number:
07787658.9
EP translation filed:
13.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
16.7.2027Expiry date:
16.7.2020
Title:
PHARMACEUTICAL DOSAGE FORM CONTAINING PHARMACEUTICALLY ACCEPTABLE SOLUBILIZING COMPOSITION
Timeline
Today
17.7.2007EP application
30.11.2016EP Publication
13.2.2017Translation submitted
15.3.2017Registration published
16.7.2020Expires
Owner
Name:
AbbVie Deutschland GmbH & Co KGAddress:
Max-Planck-Ring 2a, 65205, Wiesbaden, DE
Inventor
Name:
ROSENBERG, JörgAddress:
Ellerstadt, DE
Name:
BREITENBACH, JörgAddress:
Mannheim, DE
Name:
MARSH, KennanAddress:
Lake Forest, Illinois, US
Name:
LIEPOLD, BerndAddress:
Heidelberg, DE
Name:
SCHMIDT, ChristophAddress:
Mannheim, DE
Name:
LANDER, UteAddress:
Dannenfels, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06015076Date:
19.7.2006Country:
EP
Number:
832074 PDate:
19.7.2006Country:
US
Classification
Categories:
A61K 9/20, A61K 9/14, A61K 47/14, A61K 47/22, A61K 31/513, A61K 31/427
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 13.6.2017
Expires: 16.7.2018
Payer: Örn Þór, slf.
Number: 12
Paid: 12.6.2018
Expires: 16.7.2019
Payer: Örn Þór, slf.
Number: 13
Paid: 13.6.2019
Expires: 16.7.2020
Payer: Örn Þór, slf.